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BACKGROUND: Testicular germ cell tumors (TGCT) were suggested to have a prenatal environmentally related origin. The potential endocrine disrupt-
ing properties of certain solvents may interfere with the male genital development in utero.
OBJECTIVES:We aimed to assess the association between maternal and paternal occupational exposures to organic solvents during the prenatal period
and TGCT risk in their oﬀspring.
METHODS: This registry-based case control study included TGCT cases aged 14–49 y (n=8,112) diagnosed from 1978 to 2012 in Finland, Norway,
and Sweden. Controls (n=26,264) were randomly selected from the central population registries and were individually matched to cases on year and
country of birth. Occupational histories of parents prior to the child’s birth were extracted from the national censuses. Job codes were converted into
solvent exposure using the Nordic job-Nordic Occupational Cancer Study Job-Exposure Matrix. Conditional logistic regression was used to estimate
odds ratios (OR) and 95% conﬁdence intervals (CI).
RESULTS: Overall, no association was found between prenatal maternal exposure to solvents and TGCT risk. In subset analyses using only mothers for
whom occupational information was available in the year of or in the year prior to the child’s birth, there was an association with maternal exposure to
aromatic hydrocarbon solvents (ARHC) (OR=1:53; CI: 1.08, 2.17), driven by exposure to toluene (OR=1:67; CI: 1.02, 2.73). No association was seen
for any paternal occupational exposure to solvents with the exception of exposure to perchloroethylene in Finland (OR=2:42; CI: 1.32, 4.41).
CONCLUSIONS: This study suggests a modest increase in TGCT risk associated with maternal prenatal exposure to ARHC. https://doi.org/10.1289/
EHP864
Background
Testicular germ cell tumors (TGCT) are the most common malig-
nancy in young men aged 15 to 39 years old (Ferlay et al. 2013).
The age-standardized incidence rate of testicular cancer using the
world standard population has increased drastically in the past 40
years, recording an 8-fold increase in Finland (from 1.8 to 15.0
per 100,000 person-years), 3-fold increase in Sweden (from 4.6
to 15.4) and Norway (from 7.8 to 22.9), and a 1.5-fold increase in
Denmark (from 12.2 to 18.2) between 1970 and 2013 (Engholm
et al. 2016). This steep increase, the large geographical variation
in incidence, and the distinct patterns of incidence rates in
migrants (Schmiedel et al. 2010) support the role of environ-
mental factors in the etiology of TGCT. In Europe, prediction
of the future burden of testicular cancer up to 2025 suggests
continuing incidence increase (Le Cornet et al. 2014).
Although causes and risk factors of TGCT remain poorly
understood, the uniformly increasing incidence burden from
testicular cancer in Europe suggests increasing risk in men in
most populations, rather than ongoing changes in the national
demographic proﬁles.
While many epidemiological studies have investigated risk
factors for TGCT, ﬁndings have been inconclusive. The early age
at TGCT diagnosis, together with established associations with
congenital malformations such as cryptorchidism (Cook et al.
2010; Kratz et al. 2010) and with birth characteristics such as
birth order, parity, and low birth weight (Cook et al. 2009, 2010),
suggest a prenatal origin of TGCT. Also, at a recent international
consensus meeting, it was concluded that the common precursor
cells of TGCT (both seminomas and nonseminomas) have fetal
characteristics, including embryonic markers (Moch et al. 2016).
However, the majority of published epidemiological studies have
focused on adulthood exposures (Béranger et al. 2013).
According to the testicular dysgenesis syndrome (TDS) hy-
pothesis, TGCT, cryptorchidism, hypospadias, and reduced
sperm count originate from a common fetal disorder hampering
the normal male testicular development (Skakkebaek et al. 2016).
Exposure to endocrine-disrupting chemicals (EDCs) has been
suggested as a plausible factor for initiating TDS through
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interference with gonadal development by mimicking hormones
or interfering with hormone production (Sharpe 2006). One epi-
demiological study found the concentration of persistent organic
pollutants such as polychlorinated biphenyl (PCB), hexachloro-
benzene (HCB), and polybrominated diphenyl ethers (PBDEs) to
be signiﬁcantly higher for mothers of testicular cancer cases com-
pared to mothers of controls (Hardell et al. 2003, 2006).
Widely used solvents such as toluene, trichloroethylene, and
perchloroethylene have possible endocrine disrupting properties
(Brouwers et al. 2009), and might also interact with the masculin-
ization process in utero (Sharpe 2006). Furthermore, benzene and
trichloroethylene were classiﬁed as carcinogenic to humans
(Group 1) (IARC 2012, 2014), and perchloroethylene (also called
tetrachloroethylene) was classiﬁed as probably carcinogenic to
humans (Group 2A) by the International Agency for Research on
Cancer (IARC 2014). Organic solvents are used for extracting,
dissolving, or suspending materials such as fats, waxes, and res-
ins that are not soluble in water. Organic solvents can be found in
various commonly used products such as paints, adhesives, cos-
metics, glues, and plastics (Verma and Rana 2009), resulting in
widespread exposures. Solvent exposure is particularly high in
speciﬁc occupations and industries, such as plastic product work-
ers, chemical and food industry, well drillers, laundry workers,
and rubber product workers (Brouwers et al. 2009; Kauppinen
et al. 2009).
Little is known about the role of fetal exposures to organic sol-
vents inTGCTdevelopment (Béranger et al. 2013).Only one study,
basedon a small number of cases, investigatedparental occupations
that were potentially exposed to hydrocarbons (aircraft mechanics,
engine repairers,machinists, light truck drivers, gas and service sta-
tion attendants, painters, and printers) and found no association
withTGCT in theoﬀspring (Kardaunet al. 1991).
Given the TDS hypothesis and the endocrine properties of
some solvents such as perchloroethylene (European Commission
DG ENV 2000), we assessed parental occupational exposure to
solvents during the prenatal period and the risk of developing
TGCT in the oﬀspring in a large-scale population-based case–
control study linking the registries of the Nordic countries, the
NORD-TEST study (Le Cornet et al. 2015).
Material and Methods
Study Population
The NORD-TEST study, which has been described previously in
detail (LeCornet et al. 2015), is a registry-based case–control study
nested within the populations of Denmark, Finland, Norway, and
Sweden. All residents of the Nordic countries are registered with a
unique personal identity code, allowing linkage between registries
for tracking personal medical information and occupational status
for research purposes. The occupational information is based on job
codes derived from censuses in Finland, Norway, and Sweden and
on industry codes derived from the Supplementary Pension Fund’s
database in Denmark. As we expected that the harmonization of
data could result in uncertainty in solvent exposure estimates for
Denmark, we decided to exclude data fromDenmark from the pres-
ent pooled analysis. All testicular cancer cases diagnosed between
ages 14 and 49 y old from 1988–2012 in Finland, 1978–2010 in
Norway, and1979–2011 inSwedenwere extracted from the respec-
tive nationwide cancer registry, using the following International
Classiﬁcation of Diseases (ICD) codes: ICD-7: 178 (WHO 1955);
ICD-8 and ICD-9: 186 (WHO 1968, 1978); and ICD-O-3: C62
(WHO 2000). Four controls were randomly selected from the cen-
tral population registries andwere individuallymatched to cases by
year and country of birth.Cases and theirmatchedcontrolswere eli-
gible when they were free of any previous neoplasm (except
nonmelanoma skin cancer) and, for controls, were alive on the date
of testicular cancer diagnosis of their matched case. The parental
occupational codes (Finland, Norway, and Sweden) prior to the
cases’ or the controls’ birth had to be known for at least one of the
parents to be included in the analysis. The ﬁnal sample included
8,112 cases and 26,264 controls: 3,769 cases with four matched
controls, 2,816 cases with threematched controls, 1,213 cases with
twomatchedcontrols, and314 caseswith onematched control.
Exposure Assessment
Job codes for both parents were retrieved from the last census
conducted prior to the child’s birth and the ﬁrst census conducted
after the child's birth. The Nordic Occupational Cancer Study
Job-Exposure Matrix (NOCCA-JEM), constructed by a team of
experts in 2009 (Kauppinen et al. 2009), was used to assign pa-
rental exposures. The NOCCA-JEM converts the occupational
codes into country- and time-speciﬁc quantitative exposure esti-
mates of solvents. The parental exposure estimates were calcu-
lated as the product of the proportion of exposed workers (P)
within an occupation and the mean level of exposure to the agent
among the exposed workers (L) (Kauppinen et al. 2014). The sol-
vent exposure is expressed in parts per million (ppm) in the work-
room air for the working day. Censuses were mandatory for the
whole population in the Nordic countries and took place every
5 y in Sweden (1960–1990, except for the 1965 census) and in
Finland (1970–1990), and every 10 y in Norway (1960–1990).
The occupational exposure to solvents was estimated based on
the occupational titles recorded in the census in the year of the
child’s birth or the last census before the child’s birth.
Parental exposures available in NOCCA-JEM include the
following six individual solvents: benzene, toluene, perchloroethy-
lene, methylene chloride, trichloroethylene, and 1,1,1-trichloro-
ethane. Additionally, three groups of solvents were created, which
include the following: aromatic hydrocarbon solvents (ARHC,
combining exposure to benzene and toluene), chlorinatedhydrocar-
bon solvents (CHC, combining exposure to trichloroethanes, tri-
chloroethylene, perchloroethylene, and methylene chloride), and
“any solvent” exposure, combining exposure to the six individual
solvents.
Additional data obtained are as follows: testicular cancer fam-
ily history was retrieved for fathers and brothers of cases and
controls from the cancer registries, and information on diagnosis
and/or surgery of cryptorchidism, hypospadias, and inguinal her-
nia in cases and controls was extracted from the Medical Birth
Registry and the Hospital Discharge Registry, as well as for
Finland, from the registry of congenital malformations. Further
details have been described previously (Le Cornet et al. 2015).
Statistical Methods
Pairwise correlations between binary solvents exposure variables
were calculated using the phi coeﬃcient. Bivariate analysis was
used to assess associations of TGCT with the following factors:
father’s history of testicular cancer; brother’s history of testicular
cancer; personal history of inguinal hernia, hypospadias, and
cryptorchidism; age of father at childbirth; and age of mother at
childbirth. Conditional logistic regression was used to estimate
the strength of the associations given by odds ratios (OR) and the
corresponding 95% conﬁdence intervals (CI).
Each parental occupational exposure was classiﬁed into two
categories (exposed/unexposed) as well as, for the analyses of the
individual solvents, into three categories (unexposed, low expo-
sure, and high exposure). The cutoﬀs of exposure were speciﬁc
to each solvents’ exposure, were based on their distribution
among parents of controls, and were set at the 90th (paternal
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exposure) or 75th percentile (maternal exposure) to have enough
subjects in the high exposure category (see Table S1). It should
be noted that the estimation of exposure levels results in a semi-
quantitative variable rather than fully quantitative one, as illus-
trated with the example of methylene chloride exposure levels
among mothers and 1,1,1-trichloroethane exposure levels among
fathers in Supplementary Figure S1. This explains why in the cat-
egorization by percentile, the cutoﬀ is not always at the exact
90th or 75th cutoﬀ. It is also the reason why we decided in favor
of categorical analyses rather than more complex modeling of
dose–response trends. Models were built using the unexposed
group of each solvent individually as the reference category. Age
of father at birth, age of mother at birth, and family history of tes-
ticular cancer [father and/or brother(s)] were introduced as poten-
tial confounders in the models, but did not change the OR
estimate with any solvent by 10% or greater.
Analyses were stratiﬁed, and the results were reported by
TGCT subtype and by country. Country-speciﬁc analyses were
not conducted for maternal exposures because the number of
exposed cases was too small. The Wald test was used to assess
the heterogeneity of eﬀects across strata. An alternative analysis
was performed where the reference group was redeﬁned as those
that were not exposed to any of the solvents evaluated.
Furthermore, since there is no strong biological argument sup-
porting a role of parental exposure before 1 y of pregnancy in the
etiology of testicular cancer, a sensitivity analysis was performed
to target the conception and pregnancy time, thereby reducing the
potential misclassiﬁcation due to job changes. Therefore, the pop-
ulation was restricted to both parents for whom the census was
available the year of or the year prior to the child’s birth as well
as to parents for whom the census before and after childbirth
recorded the same occupation, assuming that the parents held this
occupation also the year of and the year prior to the child’s birth.
Additionally, the Kappa coeﬃcient was calculated to measure
the degree of agreement between prenatal and adulthood occupa-
tional exposure to solvent in cases and controls.
All analyses were performed using SAS statistical package
(version 9.3; SAS Institute, Inc.).
NORD-TEST has been approved by the relevant data protec-
tion and ethical committees in Finland, Norway, and Sweden,
and by the IARC ethics committee.
Results
A total of 8,112 TGCT cases (seminoma and nonseminoma) and
26,264 controls were included in the study. Country-speciﬁc dis-
tributions of cases and controls have been described previously
(Le Cornet et al. 2015). Table 1 shows the distributions of diﬀer-
ent characteristics for cases and controls. Overall, 94% of the
cases were diagnosed between 1990 and 2012, and 81% were
born between 1960 and 1980. The proportion of nonseminoma
cases was 55% with the median age of 26.7 years, whereas that of
seminoma was 45% with the median age of 32.2 years. About
87% of the mothers and 97% of the fathers had an occupational
status known before the child’s birth, whereof 2.3% of the moth-
ers and 13.1% of the fathers were estimated as having been
exposed to solvents in their workplace. The prevalence of occu-
pational exposure to solvents was relatively low in mothers, rang-
ing from 0.6% for perchloroethylene to 1.1% for 1,1,1-
trichloroethane. The prevalence was somewhat higher in fathers,
ranging from 1.2% for perchloroethylene to 10.7% for 1,1,1-tri-
chloroethane. Pairwise correlations between binary solvent expo-
sures ranged from 0.00 to 0.73 for maternal exposures and from
−0:01 to 0.89 for paternal exposures (Table S2). The lowest cor-
relation was found between toluene and perchloroethylene,
whereas the highest was found for trichloroethylene and 1,1,1-
trichloroethane in maternal exposures and for toluene and ben-
zene in paternal exposures.
While personal history of inguinal hernia, age of father, and
age of mother at childbirth were not associated with TGCT risk,
cryptorchidism, hypospadias, and brother’s and father’s history
of testicular cancer were associated with an increased TGCT
risk (Table 1). When the covariates considered as potential con-
founders were introduced one by one in the models, the ORs cor-
responding to solvent exposures did not change by 10% or more.
Table 1. Demographic characteristics of the study population by case–
control status and odds ratios (OR) for prenatal factors known or potentially
related to testicular cancer risk.
Demographic characteristic Cases n (%) Controls n (%) OR (95% CI)
Total 8,112 26,264
Country
Finland 1,034 (12.7) 4,030 (15.3)
Norway 3,163 (39.0) 9,089 (34.6)
Sweden 3,915 (48.3) 13,145 (50.0)
Birth year
1960–1964 1,651 (20.4) 5,352 (20.4)
1965–1969 1,489 (18.4) 4,490 (17.1)
1970–1974 1,926 (23.7) 6,398 (24.4)
1975–1979 1,518 (18.7) 4,848 (18.5)
1980–1995 1,528 (18.8) 5,176 (19.7)
Diagnostic period
1978–1989 469 (5.7)
1990–1994 825 (10.2)
1995–1999 1,376 (17.0)
2000–2004 1,965 (24.2)
2005–2009 2,517 (31.0)
2010–2012 960 (11.8)
Histological subtype
Seminoma 3,687 (45.4)
Nonseminoma 4,425 (54.6)
Age of mother at
childbirth
14–20 440 (5.4) 1,500 (5.7) 1.00
20–29 5,155 (63.6) 16,625 (63.3) 1.04 (0.93, 1.17)
30–39 2,314 (28.5) 7,484 (28.5) 1.04 (0.92, 1.17)
40+ 192 (2.4) 647 (2.5) 1.00 (0.82, 1.22)
Missing 11 (0.1) 8 (0.0)
Age of father at
childbirth
14–20 85 (1.1) 250 (1.0) 1.00
20–29 4,050 (49.9) 13,205 (50.3) 0.89 (0.69, 1.15)
30–39 3,168 (39.1) 10,353 (39.4) 0.89 (0.69, 1.14)
40+ 732 (9.0) 2,285 (8.7) 0.92 (0.71, 1.20)
Missing 77 (1.0) 171 (0.7)
Father’s history of
testicular cancer
No 8,043 (99.2) 26,192 (99.7) 1.00
Yes 69 (0.9) 72 (0.3) 2.95 (2.11, 4.12)
Brother’s history of
testicular cancer
No 8,055 (99.3) 26,230 (99.9) 1.00
Yes 57 (0.7) 34 (0.1) 5.30 (3.45, 8.12)
Personal history of
inguinal hernia
No 6,991 (86.2) 22,820 (86.9) 1.00
Yes 108 (1.3) 414 (1.6) 0.93 (0.75, 1.16)
Missing 1,013 (12.5) 3,030 (11.5)
Personal history of
hypospadias
No 7,062 (87.1) 23,187 (88.3) 1.00
Yes 37 (0.5) 47 (0.2) 2.52 (1.62, 3.90)
Missing 1,013 (12.5) 3,030 (11.5)
Personal history of
cryptorchidism
No 7,008 (86.4) 23,115 (88.0) 1.00
Yes 91 (1.1) 119 (0.5) 2.56 (1.94, 3.38)
Missing 1,013 (12.5) 3,030 (11.5)
Note: CI, confidence interval; n, number; OR, odds ratio.
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Adjusted ORs are therefore presented in the supplementary ﬁle
(Table S3). Figure 1 shows the association between prenatal pa-
rental occupational exposures to solvents and the risk of TGCT
in the oﬀspring. Slightly elevated ORs were found among sons
whose mothers were exposed to several individual solvents such
as benzene, toluene, methylene chloride, and the grouped solvent
Figure 1. Forest plot of the risk to develop testicular germ cell tumor after paternal or maternal exposure to solvents prior to birth. Odds ratios (ORs) and corre-
sponding 95% conﬁdence intervals (CIs) were derived based on logistic regression analysis conditional on year and country of child's birth, the reference cate-
gory (unexposed) was the parents that were not occupationally exposed to the solvent of interest. Aromatic hydrocarbon solvents (ARHC) include benzene
and/or toluene. Chlorinated hydrocarbon solvents (CHC) include methylene chloride, perchloroethylene, trichloroethylene, and/or 1,1,1-trichloroethane. Any
solvent category includes at least one of the following: benzene, toluene, methylene chloride, perchloroethylene, trichloroethylene, 1,1,1-trichloroethane.
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ARHC, as illustrated in Figure 1, but none of the associations
were statistically signiﬁcant. When the analysis was repeated
with a reference group of mothers occupationally not exposed to
any solvents (Table 3), the associations remained not signiﬁcant.
Similarly, the analysis for low and high levels of ARHC exposure
(Table 2) did not show an increased TGCT risk in the oﬀspring.
Only the low-exposure category to ARHC had a borderline sig-
niﬁcant association. However, the sensitivity analysis restricted
to sons born in the year of or the year after the census, or sons of
parents who held the same occupation at censuses before and af-
ter the child’s birth, showed a stronger statistically signiﬁcant
association between maternal prenatal exposure to ARHC and
TGCT in oﬀspring (OR=1:53; 95% CI: 1.08, 2.17, Table 4).
Although ORs remained slightly elevated for several individual
solvents, only toluene exposure was found signiﬁcantly associ-
ated with TGCT risk (OR=1:67; 95% CI: 1.02, 2.73, Table 4) in
the sensitivity analysis.
Most ORs associated with paternal exposures were close to
1.0. When exposure was subdivided into categories of low and
high exposures, none of the exposures in fathers were found to be
associated with TGCT risk (Table 2). In the sensitivity analyses
assessing the paternal occupational exposure to solvents in the
year of or the year prior to the childbirth, no associations with
TGCT risks in oﬀspring were found, which is consistent with the
results of the primary analysis. Stratiﬁcation by country (see
Table S4) indicated an increased TGCT risk in Finland with pre-
natal paternal exposure to perchloroethylene (OR=2:42; 95%
CI: 1.32, 4.41), and the test for heterogeneity between countries
was statistically signiﬁcant (p=0:02).
No major diﬀerences in associations were observed between
seminomas and nonseminomas for any of the maternal or pater-
nal solvent exposures (Table S5).
Discussion
In this large-scale nested case–control study of more than 8,000
TGCT cases in Finland, Norway, and Sweden, we found little
evidence of an association between parental occupational expo-
sure to solvents and the risk of TGCT in their oﬀspring. The
exception was a statistically signiﬁcant moderately increased risk
with maternal exposure to ARHC and toluene when restricting
the analysis to subjects whose maternal exposure information
near the time of pregnancy/childbirth was available, possibly
showing a stronger association than the overall analyses due to
reduced exposure misclassiﬁcation. Country-speciﬁc results
showed no additional associations besides the association with
paternal exposure to perchloroethylene, which was observed
exclusively in Finland.
The ﬁnding of a role of ARHC and toluene exposure has to
be interpreted with caution, as the number of mothers exposed
was limited in the sensitivity analysis, and the strongest associa-
tion was found in the low exposure category. Job-exposure matri-
ces (JEMs) allocate the same level and probability of exposure to
all individuals within one occupational code. The individual ex-
posure estimates are thus prone to nondiﬀerential misclassiﬁca-
tion, particularly when the probability of exposure within one
occupational code is low. The exposure categorization (low,
high) of the continuous distribution of exposure underlying ran-
dom measurement error might induce a systematic nondiﬀerential
over- or underestimation (Brenner and Loomis 1994). The bor-
derline signiﬁcant OR observed for the low category of exposure
of ARHC might be due to systematic nondiﬀerential exposure
misclassiﬁcation. However, it might be noted that nonmonotonic
dose–response curves have previously been described for expo-
sures to EDCs in relation to various endpoints (Vandenberg et al.
2016). Also, the positive association found between maternal ex-
posure to ARHC and TGCT in oﬀspring might be driven by tolu-
ene exposure, since ARHC is the combination of benzene and
toluene.
Only one other case–control study has investigated occupa-
tions of fathers and mothers potentially exposed to hydrocarbons,
but no excess risk of TGCT was observed in the oﬀspring
(Kardaun et al. 1991). However, exposure to individual chemical
agents were not assessed, and the study, including 223 cases, has
low statistical power. Several agents belonging to the group of
ARHC solvents, such as styrene or agents deriving from benzene
and toluene (pentachlorobenzene, trichlorobenzene, HCB, nitro-
toluene), have been classiﬁed in the priority list of EDCs by the
Table 2. Parental occupational exposure to solvents before the child’s birth categorized into low/high exposure and the risk of testicular germ cell tumor in the
offspring.
Agents
Level of
exposurea
Maternal exposure Paternal exposure
Cases n (%) Controls n (%) OR (95% CI)b Cases n (%) Controls n (%) OR (95% CI)b
Aromatic hydrocarbon solvents (ARHC)
Benzene Unexposed 6,932 (98.8) 22,840 (99.0) 7,315 (93.1) 23,810 (93.4)
Low 55 (0.8) 155 (0.7) 1.22 (0.89, 1.68) 267 (3.4) 862 (3.4) 1.01 (0.88, 1.16)
High 31 (0.4) 86 (0.4) 1.10 (0.71, 1.71) 273 (3.5) 824 (3.2) 1.06 (0.92, 1.22)
Toluene Unexposed 6,963 (99.2) 22,921 (99.3) 7,274 (92.6) 23,644 (92.7)
Low 40 (0.6) 110 (0.5) 1.32 (0.90, 1.93) 505 (6.4) 1,615 (6.3) 1.02 (0.92, 1.13)
High 15 (0.2) 50 (0.2) 1.01 (0.55, 1.84) 76 (1.0) 237 (0.9) 1.01 (0.77, 1.31)
Chlorinated hydrocarbon solvents (CHC)
Methylene chloride Unexposed 6,964 (99.2) 22,939 (99.4) 7,322 (93.2) 23,848 (93.5)
Low 40 (0.6) 102 (0.4) 1.36 (0.94, 1.99) 423 (5.4) 1,311 (5.1) 1.06 (0.95, 1.19)
High 14 (0.2) 40 (0.2) 1.28 (0.69, 2.40) 110 (1.4) 337 (1.3) 1.01 (0.81, 1.26)
Perchloroethylene Unexposed 6,977 (99.4) 22,956 (99.5) 7,763 (98.8) 25,220 (98.9)
Low 28 (0.4) 92 (0.4) 1.03 (0.67, 1.58) 86 (1.1) 248 (1.0) 1.11 (0.87, 1.43)
High 13 (0.2) 33 (0.1) 1.28 (0.67, 2.47) 6 (0.1) 28 (0.1) 0.67 (0.28, 1.63)
Trichloroethylene Unexposed 6,958 (99.1) 22,866 (99.1) 7,396 (94.2) 24,073 (94.4)
Low 38 (0.5) 148 (0.6) 0.85 (0.59, 1.23) 213 (2.7) 639 (2.5) 1.12 (0.96, 1.32)
High 22 (0.3) 67 (0.3) 1.06 (0.65, 1.72) 246 (3.1) 784 (3.1) 1.05 (0.91, 1.22)
1,1,1,trichloroethane Unexposed 6,937 (98.8) 22,815 (98.8) 7,017 (89.3) 22,937 (90.0)
Low 45 (0.6) 162 (0.7) 0.95 (0.68, 1.33) 380 (4.8) 1,147 (4.5) 1.10 (0.98, 1.25)
High 36 (0.5) 104 (0.5) 1.14 (0.77, 1.67) 458 (5.8) 1,412 (5.5) 1.07 (0.95, 1.19)
Note: CI, confidence interval; n, number; OR, odds ratio.
aThe exposed group was divided into two groups, based on the 75th percentile of mothers who were exposed and on the 90th percentile of fathers who were exposed.
bORs and the corresponding 95% CIs were derived based on logistic regression analysis conditional on year and country of child’s birth. The reference category (unexposed) consists
of the parents who were not occupationally exposed to the solvent of interest.
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European Commission (European Commission DG ENV 2000).
Exposure to EDCs has been suggested to contribute to the devel-
opment of TDS through interference with hormone synthesis,
secretion, and signaling (Cook et al. 2011; Giordano et al. 2010;
Sharpe 2006). In two studies, fetal exposure to toluene and sty-
rene was reported to be associated with a reduced synthesis and
secretion of testosterone in the fetal testes and decreased weight
of male reproductive organs (Ohyama et al. 2007; Tsukahara
et al. 2009).
One study reported a positive association between fathers
working as painters and occupationally exposed to organic sol-
vents within the 3 months before pregnancy and birth defect risk
in children (Hooiveld et al. 2006). Our results on overall expo-
sure to solvents do not support the association observed in this
study, but the two studies are diﬃcult to compare, since in the
study by Hooiveld et al. (2006), the number of children with birth
defects was very small (n=48) and involved a wide range of
congenital malformations and disorders. The mechanisms under-
lying a potential eﬀect of paternal exposure to solvents on TGCT
in oﬀspring is unclear, but a plausible pathway has been hypothe-
sized; notably an eﬀect on sperm DNA, producing mutations or
chromosomal abnormalities (Olshan et al. 1991). Although ex-
perimental studies have supported a potential eﬀect of solvent ex-
posure on the testes, none have investigated the corresponding
eﬀect of paternal exposure on the testes in the oﬀspring (Lamb
and Hentz 2006; NTP 2002; Verma and Rana 2009; Xu et al.
2004). Therefore, the association found for paternal exposure to
perchloroethylene in our study requires further support from
mechanistic studies. However, it should be noted that neither the
prevalence of exposure nor the exposure levels among the
exposed to perchloroethylene were substantially higher in
Finland compared to Norway or Sweden. While the diﬀerences
in ORs observed across the countries might be explained by
some diﬀerence in occupational practices, we cannot exclude the
possibility of an observation by chance due to multiple
comparisons.
The main advantage of the NORD-TEST study is the linkage
between the population-based registries from the Nordic coun-
tries representing an exceptional setting to design a retrospec-
tive study, with access to prospectively registered exposure
information. The extraction of the cases diagnosed during the
last 30 years in three countries provides a large sample size to
analyze parental occupational exposure to organic solvents,
even though the prevalence of exposure remained limited for
certain solvents and exposure categories. Another strength is
the use of a country-speciﬁc JEM created for Nordic countries
(NOCCA-JEM) that encompasses the exposure estimates of
single substances that are likely to have their own mechanisms
Table 3. Parental occupational exposure to different solvents before childbirth and TGCT in the offspring with unexposed to any of the solvents as reference
category.
Exposure
Maternal exposure Paternal exposure
Cases n (%) Controls n (%) OR (95% CI)a Cases n (%) Controls n (%) OR (95% CI)a
Aromatic hydrocarbon solvents (ARHC)
Any of ARHC solventsb
Unexposed 6,825 (97.2) 22,519 (97.6) 6,698 (85.3) 21,879 (85.8)
Exposed 104 (1.5) 287 (1.2) 1.23 (0.97, 1.55) 612 (7.8) 1,951 (7.7) 1.03 (0.93, 1.13)
Exposed only to others 89 (1.3) 275 (1.2) 1.09 (0.86, 1.40) 545 (6.9) 1,666 (6.5) 1.10 (1.00, 1.22)
Benzene
Unexposed 6,825 (97.2) 22,519 (97.6) 6,698 (85.3) 21,879 (85.8)
Exposed 86 (1.2) 241 (1.0) 1.18 (0.91, 1.53) 540 (6.9) 1,686 (6.6) 1.04 (0.94, 1.15)
Exposed only to others 107 (1.5) 321 (1.4) 1.15 (0.91, 1.44) 617 (7.9) 1,931 (7.6) 1.08 (0.98, 1.19)
Toluene
Unexposed 6,825 (97.2) 22,519 (97.6) 6,698 (85.3) 21,879 (85.8)
Exposed 55 (0.8) 160 (0.7) 1.22 (0.89, 1.69) 581 (7.4) 1,852 (7.3) 1.02 (0.93, 1.13)
Exposed only to others 138 (2.0) 402 (1.7) 1.14 (0.93, 1.39) 576 (7.3) 1,765 (6.9) 1.10 (1.00, 1.22)
Chlorinated hydrocarbon solvents (CHC)
Any of CHC solventsc
Unexposed 6,825 (97.2) 22,519 (97.6) 6,698 (85.3) 21,879 (85.8)
Exposed 108 (1.5) 344 (1.5) 1.06 (0.85, 1.32) 967 (12.3) 2,972 (11.7) 1.07 (0.99, 1.16)
Exposed only to others 85 (1.2) 218 (0.9) 1.33 (1.03, 1.73) 190 (2.4) 645 (2.5) 1.00 (0.85, 1.18)
Methylene chloride
Unexposed 6,825 (97.2) 22,519 (97.6) 6,698 (85.3) 21,879 (85.8)
Exposed 54 (0.8) 142 (0.6) 1.34 (0.97, 1.86) 533 (6.8) 1,648 (6.5) 1.06 (0.95, 1.17)
Exposed only to others 139 (2.0) 420 (1.8) 1.10 (0.90, 1.35) 624 (7.9) 1,969 (7.7) 1.07 (0.97, 1.17)
Perchloroethylene
Unexposed 6,825 (97.2) 22,519 (97.6) 6,698 (85.3) 21,879 (85.8)
Exposed 41 (0.6) 125 (0.5) 1.10 (0.77, 1.58) 92 (1.2) 276 (1.1) 1.08 (0.84, 1.37)
Exposed only to others 152 (2.2) 437 (1.9) 1.18 (0.97, 1.43) 1,065 (13.6) 3,341 (13.1) 1.06 (0.98, 1.14)
Trichloroethylene
Unexposed 6,825 (97.2) 22,519 (97.6) 6,698 (85.3) 21,879 (85.8)
Exposed 60 (0.9) 215 (0.9) 0.93 (0.69, 1.24) 459 (5.8) 1,423 (5.6) 1.09 (0.98, 1.22)
Exposed only to others 133 (1.9) 347 (1.5) 1.31 (1.06, 1.61) 698 (8.9) 2,194 (8.6) 1.04 (0.95, 1.14)
1,1,1,trichloroethane
Unexposed 6,825 (97.2) 22,519 (97.6) 6,698 (85.3) 21,879 (85.8)
Exposed 81 (1.2) 266 (1.2) 1.03 (0.80, 1.33) 838 (10.7) 2,559 (10.0) 1.08 (1.00, 1.18)
Exposed only to others 112 (1.6) 296 (1.3) 1.28 (1.02, 1.61) 319 (4.1) 1,058 (4.1) 1.01 (0.88, 1.14)
Note: CI, confidence interval; n, number; OR, odds ratio; TGCT, testicular germ cell tumor risk; Exposed, exposed to the solvents of interest but can also be exposed to other solvents;
Exposed only to others, exposed to any other solvents but the solvent of interest; Unexposed, unexposed to any of the individual or groups of solvents.
aORs and the corresponding 95% CIs were derived based on logistic regression analysis conditional on year and country of child’s birth, the reference category (unexposed) being the
parents that were occupationally unexposed to any of the individual or groups of solvents.
bBenzene and/or toluene.
cMethylene chloride, perchloroethylene, trichloroethylene, and/or 1,1,1-trichloroethane.
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of action in contrast to groups of substances (Pukkala et al.
2009). One of the advantages of using a JEM is that it assigns
occupational exposures in a systematic and objective way,
therefore avoiding diﬀerential misclassiﬁcation between cases
and controls; this is particularly true for the NORD-TEST
study collecting occupational data via censuses, which were
carried out before the diagnosis of TGCT.
One of the limitations of the NORD-TEST study is the lack of
information on the time and duration of each occupation and there-
fore the inability to precisely target the critical time window of ex-
posure and calculate preconception cumulative exposures. Because
of the study design, we had to assume that the job at the time of cen-
sus reﬂected the exposure at the time of conception and during intra-
uterine development, even though the census might be several years
before the child’s birth. Nevertheless, the sensitivity analyses,
including parents for whom the census was availablewithin the year
before or the year of the child’s birth or parents who held the same
occupation incensusprior andafter the child’s birth, yielded stronger
associations. In addition, NOCCA-JEM assumes homogeneity of
exposure within jobs. The true variance of solvent exposure within
jobs represented by equal levels of exposure might have diluted the
estimated strength of a possible association. Nevertheless, our
approach allowed us to compare the parents with a higher risk of sol-
vent exposurewith thosewith a lower risk of solvent exposure.
A recent hypothesis suggests that TGCT could arise from a
combined eﬀect of prenatal and early- and later-life exposures
(McGlynn and Trabert 2012). The germ cell neoplasia in situ
(Berney et al. 2016) assumed to be generated in utero by primary
prenatal exposure doesnot become invasive until puberty following
activation of the pituitary–gonadal axis (Rajpert-De 2006;
Skakkebaek et al. 1987, 2001; Sonne et al. 2009). The design of
NORD-TEST study did not allow collection of individual lifelong
exposures. However, some of the subjects had a known occupa-
tional history. With this information, we checked whether subjects
exposed to solvents during the prenatal period were likely to be
exposed later in life in their occupations, but found this was not the
case (as measured by the kappa statistics of agreement of categori-
cal variables;j≤ 0:1).
Conclusions
This is the ﬁrst large nested case–control study investigating asso-
ciations between maternal and paternal exposure to several indi-
vidual organic solvents and types of them, and the risk of TGCT
in their oﬀspring. We found no evidence of any association with
paternal occupational exposure to solvents, except an elevated risk
observed with perchloroethylene in Finland only. For maternal ex-
posure, a moderately elevated risk was observed among sons of
mothers occupationally exposed to ARHC, particularly toluene,
when analyses were restricted to mothers for whom the occupation
was known in the year of or the year before childbirth. Further
studies are needed, including investigations of molecular mecha-
nisms, to better understand the observed association between
maternal exposures to toluene and TGCT risk in their oﬀspring.
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Exposure
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Methylene chloride
Unexposed 4,037 (99.4) 13,646 (99.6) 4,064 (92.6) 13,636 (92.9)
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aORs and the corresponding 95% CIs were derived based on logistic regression analysis conditional on year and country of child’s birth, the reference category (unexposed) was the
parents that were not occupationally exposed to the solvent of interest.
bBenzene and/or toluene.
cMethylene chloride, perchloroethylene, trichloroethylene, and/or 1,1,1-trichloroethane.
dAt least one of the following solvents: benzene, toluene, methylene chloride, perchloroethylene, trichloroethylene, 1,1,1-trichloroethane.
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